Changes announced to Rebif listing on PBS

3 November 2022 - From 1 December 2022, Rebif will no longer be available on the PBS for Australians living with ...

Read more →

Outcome statement - September 2022 DUSC meeting

3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...

Read more →

Department tweaks the agenda for the Nov 2022 PBAC meeting yet again

2 November 2022 - Two changes made on the eve of the meeting. ...

Read more →

First immunotherapy for patients with a potentially life threatening type of non-melanoma skin cancer now available on the PBS

1 November 2022 - Australians with a potentially life-threatening type of non-melanoma skin cancer will for the first time, have ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2022

1 November 2022 - The November 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

1 November 2022 updates as part of the digital transformation of Authority Required (Written) PBS listings

1 November 2022 - From 1 November 2022, the PBS listings for certain medicines will be updated as part of the ...

Read more →

Expanded access to COVID-19 oral antiviral treatments on the PBS

1 November 2022 - Expanded eligibility criteria for COVID-19 oral anti-viral treatments (Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir) ...

Read more →

Department of Health tweaks the agenda for this week's PBAC meeting

28 October 2022 - The is one late change to the agenda for the November meeting. ...

Read more →

Public Summary Documents – July 2022 PBAC meeting

28 October 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2022 PBAC ...

Read more →

Health technology assessment review – frequently asked questions

27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming ...

Read more →

Cheaper medicines legislation passed

27 October 2022 - The Australian Government’s legislation, which will see millions of Australians pay 29% less for scripts with the ...

Read more →

Independent chair of health technology assessment review will drive major reform of Australia’s health system

27 October 2022 - Medicines Australia welcomes the appointment of Adjunct Professor Debora Picone AO as independent Chair of the ...

Read more →

Reference Committee for the health technology assessment policy and methods review

27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, ...

Read more →

HTA review and chair committee

27 October 2022 - The Government today announced the appointment of Adjunct Professor Debora Picone AO as Chair of the Health ...

Read more →

October Budget 2022-23: a no surprise budget for health

25 October 2022 - Medicines Australia welcomes tonight’s Budget which take steps towards addressing economic pressures and introduces new funding ...

Read more →